Loading...
Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
BACKGROUND: Most current guidelines do not recommend the serial analysis of tumour marker CA 15.3 in the follow-up of asymptomatic patients treated for early breast cancer (EBC). These guidelines are based on small-scale studies carried out in an era with more limited treatment options than today. I...
Na minha lista:
| Udgivet i: | ESMO Open |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282974/ https://ncbi.nlm.nih.gov/pubmed/34271308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100203 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|